Estrogen-bridged purines: a new series of anti-tumor agents which alter cell membrane properties.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D003515:Cycloleucine / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects; D004317:Doxorubicin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D004967:Estrogens / Q000627:therapeutic use*; D007941:Leukemia P388 / Q000188:drug therapy* / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D011687:Purines / Q000627:therapeutic use*; D013936:Thymidine / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014529:Uridine / Q000378:metabolism
D004967:Estrogens; D011687:Purines; D003515:Cycloleucine; D004317:Doxorubicin; D013936:Thymidine; D014529:Uridine